Back to top

AEON Biopharma regains NYSE American listing compliance after $13.6M offering

AEON Biopharma regains NYSE American listing compliance after $13.6M offering

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AEON Biopharma, Inc. (AEON)